Why Pregnant Women Are Still Missing From Drug Trials and Why It Matters Now episode artwork

EPISODE · Oct 13, 2025 · 13 MIN

Why Pregnant Women Are Still Missing From Drug Trials and Why It Matters Now

from The Gist Healthcare Podcast

For decades, pregnant women have been excluded from most clinical drug trials. The policy was meant to protect mothers and babies, but it has left major gaps in medical knowledge. Now, renewed debate over the safety of common medicines like Tylenol has brought those gaps into sharp focus.   In this episode, STAT News reporter Lizzy Lawrence joins host J. Carlisle Larsen to discuss how history, politics, and caution shaped the science of pregnancy, and what it will take to ensure women are fully included in research that affects their health.  You can read her piece here.   Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Oct 13, 2025

Embed this episode

NOW PLAYING

Why Pregnant Women Are Still Missing From Drug Trials and Why It Matters Now

0:00 13:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 13 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on October 13, 2025.

Can I download this The Gist Healthcare Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!